NOVEL TARGET FOR ANTI-CANCER AND IMMUNE-ENHANCING
The present disclosure provides a pharmaceutical composition for treating or preventing cancer, comprising inhibitors of KIRREL3, CNTN4 and/or CD351. In addition, the present disclosure provides a pharmaceutical composition for immune-enhancing, comprising inhibitors of KIRREL3, CNTN4 and/or CD351....
Gespeichert in:
| Hauptverfasser: | , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre ; ger |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | YOON, Kyoung-Wan SOHN, Jinyoung KIM, Yun Yeon JEON, Bu-Nam HOUH, Youn Kyung LEE, Suro CHUNG, Joo-Yeon JEONG, Areum |
| description | The present disclosure provides a pharmaceutical composition for treating or preventing cancer, comprising inhibitors of KIRREL3, CNTN4 and/or CD351. In addition, the present disclosure provides a pharmaceutical composition for immune-enhancing, comprising inhibitors of KIRREL3, CNTN4 and/or CD351. Furthermore, the present disclosure provides a method of screening of anti-cancer agent using KIRREL3, CNTN4 and/or CD351, and a method of providing information necessary for analysis of cancer prognosis using KIRREL3, CNTN4 and/or CD351. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_EP3775889A4</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>EP3775889A4</sourcerecordid><originalsourceid>FETCH-epo_espacenet_EP3775889A43</originalsourceid><addsrcrecordid>eNrjZDD08w9z9VEIcQxydw1RcPMPUnD0C_HUdXb0c3YFsV0UPH19Q_1cdV39PIBinn7uPAysaYk5xam8UJqbQcHNNcTZQze1ID8-tbggMTk1L7Uk3jXA2Nzc1MLC0tHEmAglAO_yJhE</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>NOVEL TARGET FOR ANTI-CANCER AND IMMUNE-ENHANCING</title><source>esp@cenet</source><creator>YOON, Kyoung-Wan ; SOHN, Jinyoung ; KIM, Yun Yeon ; JEON, Bu-Nam ; HOUH, Youn Kyung ; LEE, Suro ; CHUNG, Joo-Yeon ; JEONG, Areum</creator><creatorcontrib>YOON, Kyoung-Wan ; SOHN, Jinyoung ; KIM, Yun Yeon ; JEON, Bu-Nam ; HOUH, Youn Kyung ; LEE, Suro ; CHUNG, Joo-Yeon ; JEONG, Areum</creatorcontrib><description>The present disclosure provides a pharmaceutical composition for treating or preventing cancer, comprising inhibitors of KIRREL3, CNTN4 and/or CD351. In addition, the present disclosure provides a pharmaceutical composition for immune-enhancing, comprising inhibitors of KIRREL3, CNTN4 and/or CD351. Furthermore, the present disclosure provides a method of screening of anti-cancer agent using KIRREL3, CNTN4 and/or CD351, and a method of providing information necessary for analysis of cancer prognosis using KIRREL3, CNTN4 and/or CD351.</description><language>eng ; fre ; ger</language><subject>BEER ; BIOCHEMISTRY ; CHEMISTRY ; COMPOSITIONS OR TEST PAPERS THEREFOR ; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES ; ENZYMOLOGY ; INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES ; MEASURING ; MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS ; METALLURGY ; MICROBIOLOGY ; MUTATION OR GENETIC ENGINEERING ; PHYSICS ; PROCESSES OF PREPARING SUCH COMPOSITIONS ; SPIRITS ; TESTING ; VINEGAR ; WINE</subject><creationdate>2022</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220803&DB=EPODOC&CC=EP&NR=3775889A4$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220803&DB=EPODOC&CC=EP&NR=3775889A4$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>YOON, Kyoung-Wan</creatorcontrib><creatorcontrib>SOHN, Jinyoung</creatorcontrib><creatorcontrib>KIM, Yun Yeon</creatorcontrib><creatorcontrib>JEON, Bu-Nam</creatorcontrib><creatorcontrib>HOUH, Youn Kyung</creatorcontrib><creatorcontrib>LEE, Suro</creatorcontrib><creatorcontrib>CHUNG, Joo-Yeon</creatorcontrib><creatorcontrib>JEONG, Areum</creatorcontrib><title>NOVEL TARGET FOR ANTI-CANCER AND IMMUNE-ENHANCING</title><description>The present disclosure provides a pharmaceutical composition for treating or preventing cancer, comprising inhibitors of KIRREL3, CNTN4 and/or CD351. In addition, the present disclosure provides a pharmaceutical composition for immune-enhancing, comprising inhibitors of KIRREL3, CNTN4 and/or CD351. Furthermore, the present disclosure provides a method of screening of anti-cancer agent using KIRREL3, CNTN4 and/or CD351, and a method of providing information necessary for analysis of cancer prognosis using KIRREL3, CNTN4 and/or CD351.</description><subject>BEER</subject><subject>BIOCHEMISTRY</subject><subject>CHEMISTRY</subject><subject>COMPOSITIONS OR TEST PAPERS THEREFOR</subject><subject>CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES</subject><subject>ENZYMOLOGY</subject><subject>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES</subject><subject>MEASURING</subject><subject>MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS</subject><subject>METALLURGY</subject><subject>MICROBIOLOGY</subject><subject>MUTATION OR GENETIC ENGINEERING</subject><subject>PHYSICS</subject><subject>PROCESSES OF PREPARING SUCH COMPOSITIONS</subject><subject>SPIRITS</subject><subject>TESTING</subject><subject>VINEGAR</subject><subject>WINE</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2022</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDD08w9z9VEIcQxydw1RcPMPUnD0C_HUdXb0c3YFsV0UPH19Q_1cdV39PIBinn7uPAysaYk5xam8UJqbQcHNNcTZQze1ID8-tbggMTk1L7Uk3jXA2Nzc1MLC0tHEmAglAO_yJhE</recordid><startdate>20220803</startdate><enddate>20220803</enddate><creator>YOON, Kyoung-Wan</creator><creator>SOHN, Jinyoung</creator><creator>KIM, Yun Yeon</creator><creator>JEON, Bu-Nam</creator><creator>HOUH, Youn Kyung</creator><creator>LEE, Suro</creator><creator>CHUNG, Joo-Yeon</creator><creator>JEONG, Areum</creator><scope>EVB</scope></search><sort><creationdate>20220803</creationdate><title>NOVEL TARGET FOR ANTI-CANCER AND IMMUNE-ENHANCING</title><author>YOON, Kyoung-Wan ; SOHN, Jinyoung ; KIM, Yun Yeon ; JEON, Bu-Nam ; HOUH, Youn Kyung ; LEE, Suro ; CHUNG, Joo-Yeon ; JEONG, Areum</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_EP3775889A43</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre ; ger</language><creationdate>2022</creationdate><topic>BEER</topic><topic>BIOCHEMISTRY</topic><topic>CHEMISTRY</topic><topic>COMPOSITIONS OR TEST PAPERS THEREFOR</topic><topic>CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES</topic><topic>ENZYMOLOGY</topic><topic>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES</topic><topic>MEASURING</topic><topic>MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS</topic><topic>METALLURGY</topic><topic>MICROBIOLOGY</topic><topic>MUTATION OR GENETIC ENGINEERING</topic><topic>PHYSICS</topic><topic>PROCESSES OF PREPARING SUCH COMPOSITIONS</topic><topic>SPIRITS</topic><topic>TESTING</topic><topic>VINEGAR</topic><topic>WINE</topic><toplevel>online_resources</toplevel><creatorcontrib>YOON, Kyoung-Wan</creatorcontrib><creatorcontrib>SOHN, Jinyoung</creatorcontrib><creatorcontrib>KIM, Yun Yeon</creatorcontrib><creatorcontrib>JEON, Bu-Nam</creatorcontrib><creatorcontrib>HOUH, Youn Kyung</creatorcontrib><creatorcontrib>LEE, Suro</creatorcontrib><creatorcontrib>CHUNG, Joo-Yeon</creatorcontrib><creatorcontrib>JEONG, Areum</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>YOON, Kyoung-Wan</au><au>SOHN, Jinyoung</au><au>KIM, Yun Yeon</au><au>JEON, Bu-Nam</au><au>HOUH, Youn Kyung</au><au>LEE, Suro</au><au>CHUNG, Joo-Yeon</au><au>JEONG, Areum</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>NOVEL TARGET FOR ANTI-CANCER AND IMMUNE-ENHANCING</title><date>2022-08-03</date><risdate>2022</risdate><abstract>The present disclosure provides a pharmaceutical composition for treating or preventing cancer, comprising inhibitors of KIRREL3, CNTN4 and/or CD351. In addition, the present disclosure provides a pharmaceutical composition for immune-enhancing, comprising inhibitors of KIRREL3, CNTN4 and/or CD351. Furthermore, the present disclosure provides a method of screening of anti-cancer agent using KIRREL3, CNTN4 and/or CD351, and a method of providing information necessary for analysis of cancer prognosis using KIRREL3, CNTN4 and/or CD351.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; fre ; ger |
| recordid | cdi_epo_espacenet_EP3775889A4 |
| source | esp@cenet |
| subjects | BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS OR TEST PAPERS THEREFOR CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES ENZYMOLOGY INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES MEASURING MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS METALLURGY MICROBIOLOGY MUTATION OR GENETIC ENGINEERING PHYSICS PROCESSES OF PREPARING SUCH COMPOSITIONS SPIRITS TESTING VINEGAR WINE |
| title | NOVEL TARGET FOR ANTI-CANCER AND IMMUNE-ENHANCING |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T23%3A06%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=YOON,%20Kyoung-Wan&rft.date=2022-08-03&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EEP3775889A4%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |